The Filing Desk

Anika Therapeutics vs Owlet

Anika Therapeutics ANIK · Owlet OWLT · Health Care Equipment

Anika Therapeutics reported revenue of $113 million in fiscal 2025, about the same as Owlet's $106 million in fiscal 2025. Anika Therapeutics' revenue fell 5.9% in its latest year, and Owlet's grew 35.4%. Anika Therapeutics had an operating margin of -9.8%, against -7.8% at Owlet. Free cash flow was $4 million at Anika Therapeutics and −$11 million at Owlet.

Side by side

Anika TherapeuticsOwlet
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$113M$106M
Revenue growth−5.9%35.4%
Revenue growth a year, last 5 years−2.9%7.0%
Gross margin56.6%50.6%
Operating margin−9.8%−7.8%
Net margin−9.6%−37.5%
Free cash flow$4M−$11M
Free cash flow margin3.9%−10.5%
Return on capital——
Net debt to EBITDA——
Dividends and buybacks$10M$0M
Change in diluted share count−2.6%65.2%
Last close$13.28$3.23
P/E at the last close——
Insider trades, last 12 monthsbought $264,308, sold $0sold $295,978
Piotroski F-score—5 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Anika TherapeuticsOwlet
Operating margin
Percent of revenue
Anika TherapeuticsOwlet
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Anika TherapeuticsOwlet

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Anika Therapeutics and Owlet pages.